Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients

NCT05002140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastasis
Locally Advanced Solid Tumor
Recurrent Cancer

Interventions

DRUG: XRD-0394
RADIATION: Palliative radiotherapy

Sponsor

XRad Therapeutics Inc